DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 10647


Protein Approved Unknown SUBCUTANEOUS Diabetes Mellitus, Type 1; Parkinson Disease; Acute Coronary Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 2 Glucagon-like peptide 1 receptor agonist


Small molecule Approved Unknown ORAL Amyloidosis, Familial; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; HIV Infections; Idiopathic Pulmonary Fibrosis; Kidney Diseases; Leukemia, Myelomonocytic, Chronic; Leukemia, Prolymphocytic; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Cutaneous; Prostatic Neoplasms; Small Cell Lung Carcinoma; Amyloidosis; Blastic Plasmacytoid Dendritic Cell Neoplasm; Breast Neoplasms; Hematologic Neoplasms; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Prolymphocytic, T-Cell; Leukemia, Promyelocytic, Acute; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Multiple Myeloma; Myelodysplastic Syndromes; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms Apoptosis regulator Bcl-2 inhibitor

Small molecule

Approved

Unknown

ORAL

Amyloidosis, Familial; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; HIV Infections; Idiopathic Pulmonary Fibrosis; Kidney Diseases; Leukemia, Myelomonocytic, Chronic; Leukemia, Prolymphocytic; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Cutaneous; Prostatic Neoplasms; Small Cell Lung Carcinoma; Amyloidosis; Blastic Plasmacytoid Dendritic Cell Neoplasm; Breast Neoplasms; Hematologic Neoplasms; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Prolymphocytic, T-Cell; Leukemia, Promyelocytic, Acute; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Multiple Myeloma; Myelodysplastic Syndromes; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms

Apoptosis regulator Bcl-2 inhibitor


Small molecule Approved Unknown Unknown Hepatitis, Viral, Human; Hepatitis C; Hepatitis C, Chronic; Virus Diseases Nonstructural protein 5A inhibitor


Protein Approved Unknown ORAL Irritable Bowel Syndrome; Constipation Heat-stable enterotoxin receptor agonist


Small molecule Approved Unknown INTRAVENOUS; ORAL Graft vs Host Disease; Pregnancy; Cytomegalovirus Infections; Infections; Virus Diseases DNA terminase inhibitor


Antibody Approved Unknown INJECTION Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, T-Cell, Cutaneous; Neoplasm Metastasis; Plasmacytoma; Polycythemia Vera; Primary Myelofibrosis; Skin Neoplasms; Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Follicular; Adenocarcinoma of Lung; Anus Neoplasms; Bile Duct Neoplasms; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Dysgerminoma; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; Hemangiosarcoma; Hepatitis B, Chronic; Inflammatory Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Sarcoma; Seminoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Urogenital Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Endometrial Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Mesothelioma; Oropharyngeal Neoplasms; Ovarian Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Small Cell Lung Carcinoma Programmed cell death 1 ligand 1 inhibitor

Antibody

Approved

Unknown

INJECTION

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, T-Cell, Cutaneous; Neoplasm Metastasis; Plasmacytoma; Polycythemia Vera; Primary Myelofibrosis; Skin Neoplasms; Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Follicular; Adenocarcinoma of Lung; Anus Neoplasms; Bile Duct Neoplasms; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Dysgerminoma; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; Hemangiosarcoma; Hepatitis B, Chronic; Inflammatory Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Sarcoma; Seminoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Urogenital Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Endometrial Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Mesothelioma; Oropharyngeal Neoplasms; Ovarian Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Small Cell Lung Carcinoma

Programmed cell death 1 ligand 1 inhibitor


Antibody Approved Unknown INJECTION Hemophilia A; Hemorrhage Coagulation factor IX and X other


Antibody Approved Unknown INJECTION Scleroderma, Systemic; Arthritis, Rheumatoid; Asthma; Crohn Disease; Hidradenitis Suppurativa; Arthritis, Psoriatic; Spondylitis, Ankylosing; Immune System Diseases; Psoriasis Interleukin-17 receptor A antagonist


Protein Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown Unknown Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Renal Insufficiency; Urinary Bladder Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Endometrial Neoplasms; Gallbladder Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Neoplasms PI3-kinase p110-alpha subunit inhibitor

Small molecule

Approved

Unknown

Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Renal Insufficiency; Urinary Bladder Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Endometrial Neoplasms; Gallbladder Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Neoplasms

PI3-kinase p110-alpha subunit inhibitor


Protein Approved Unknown INTRAVENOUS Renal Insufficiency, Chronic; Hyperparathyroidism, Secondary; Parathyroid Diseases Calcium sensing receptor agonist


Small molecule Approved Unknown ORAL Lymphoma, Large-Cell, Anaplastic; Carcinoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms ALK tyrosine kinase receptor inhibitor


Small molecule Approved Unknown Unknown Carcinoid Tumor; Diarrhea; Neuroendocrine Tumors Tryptophan 5-hydroxylase inhibitor


Antibody Approved Unknown INJECTION Carcinoma, Non-Small-Cell Lung; Food Hypersensitivity; Skin Diseases; Alopecia Areata; Angioedema; Aspergillosis, Allergic Bronchopulmonary; Colitis, Ulcerative; Conjunctivitis, Allergic; Hypereosinophilic Syndrome; Hypersensitivity; Keloid; Netherton Syndrome; Peanut Hypersensitivity; Pemphigoid, Bullous; Prostatic Neoplasms, Castration-Resistant; Respiratory Tract Diseases; Rhinitis, Allergic, Seasonal; Scleroderma, Localized; Severe Acute Respiratory Syndrome; Urticaria; Chronic Urticaria; Cold Urticaria; Dermatitis; Eosinophilic Esophagitis; Neurodermatitis; Pruritus; Pulmonary Disease, Chronic Obstructive; Asthma; Dermatitis, Atopic; Eczema; Esophageal Diseases; Nasal Polyps; Prurigo; Sinusitis Interleukin-4 receptor subunit alpha antagonist

Antibody

Approved

Unknown

INJECTION

Carcinoma, Non-Small-Cell Lung; Food Hypersensitivity; Skin Diseases; Alopecia Areata; Angioedema; Aspergillosis, Allergic Bronchopulmonary; Colitis, Ulcerative; Conjunctivitis, Allergic; Hypereosinophilic Syndrome; Hypersensitivity; Keloid; Netherton Syndrome; Peanut Hypersensitivity; Pemphigoid, Bullous; Prostatic Neoplasms, Castration-Resistant; Respiratory Tract Diseases; Rhinitis, Allergic, Seasonal; Scleroderma, Localized; Severe Acute Respiratory Syndrome; Urticaria; Chronic Urticaria; Cold Urticaria; Dermatitis; Eosinophilic Esophagitis; Neurodermatitis; Pruritus; Pulmonary Disease, Chronic Obstructive; Asthma; Dermatitis, Atopic; Eczema; Esophageal Diseases; Nasal Polyps; Prurigo; Sinusitis

Interleukin-4 receptor subunit alpha antagonist


Small molecule Approved Unknown Unknown Hepatitis C; Hepatitis C, Chronic Hepatitis C virus serine protease, NS3/NS4A inhibitor


Protein Approved Unknown ORAL; SUBCUTANEOUS Bone Diseases, Metabolic; Alcoholism; Asthma; Depressive Disorder, Major; Diabetic Nephropathies; Ischemic Stroke; Liver Diseases; Parkinson Disease; Polycystic Ovary Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Alzheimer Disease; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 1; Klinefelter Syndrome; Non-alcoholic Fatty Liver Disease; Nutrition Disorders; Pseudotumor Cerebri; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight Glucagon-like peptide 1 receptor agonist

Protein

Approved

Unknown

ORAL; SUBCUTANEOUS

Bone Diseases, Metabolic; Alcoholism; Asthma; Depressive Disorder, Major; Diabetic Nephropathies; Ischemic Stroke; Liver Diseases; Parkinson Disease; Polycystic Ovary Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Alzheimer Disease; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 1; Klinefelter Syndrome; Non-alcoholic Fatty Liver Disease; Nutrition Disorders; Pseudotumor Cerebri; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight

Glucagon-like peptide 1 receptor agonist


Unknown Approved Unknown Unknown Unknown Unknown


Antibody Approved Unknown INJECTION Lymphoma, Non-Hodgkin; Psychotic Disorders; Schizophrenia; Autoimmune Diseases of the Nervous System; Arthritis, Rheumatoid; Lupus Erythematosus, Systemic; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting B-lymphocyte antigen CD20 binding agent


Protein Approved Unknown INTRAVENOUS Hypotension; Shock; Shock, Septic Type-1 angiotensin II receptor agonist


Antibody Approved Unknown INJECTION Fallopian Tube Neoplasms; Lung Neoplasms; Prostatic Neoplasms, Castration-Resistant; Scleroderma, Localized; Arthritis, Juvenile; Mastocytosis, Systemic; Melanoma; Sarcoidosis; Spondylitis, Ankylosing; Uveitis; Giant Cell Arteritis; Influenza, Human; Pneumonia; Polymyalgia Rheumatica; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Immune System Diseases Interleukin-6 receptor alpha subunit antagonist

Antibody

Approved

Unknown

INJECTION

Fallopian Tube Neoplasms; Lung Neoplasms; Prostatic Neoplasms, Castration-Resistant; Scleroderma, Localized; Arthritis, Juvenile; Mastocytosis, Systemic; Melanoma; Sarcoidosis; Spondylitis, Ankylosing; Uveitis; Giant Cell Arteritis; Influenza, Human; Pneumonia; Polymyalgia Rheumatica; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Immune System Diseases

Interleukin-6 receptor alpha subunit antagonist


Small molecule Approved Unknown ORAL Carcinoma, Renal Cell; Colorectal Neoplasms; Cystadenocarcinoma, Serous; Diffuse Intrinsic Pontine Glioma; Glioma; Lymphoma; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasm Metastasis; Neuroblastoma; Neurofibromatosis 1; Osteosarcoma; Ovarian Neoplasms; Prostatic Neoplasms; Rhabdoid Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Urinary Bladder Neoplasms; Biliary Tract Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Endometrial Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; Hemangiosarcoma; Lung Neoplasms; Lymphoma, Mantle-Cell; Melanoma; Meningioma; Mesothelioma; Neuroendocrine Tumors; Oligodendroglioma; Paraganglioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung; Liposarcoma; Breast Neoplasms; Neoplasms Cyclin-dependent kinase 4 inhibitor

Small molecule

Approved

Unknown

ORAL

Carcinoma, Renal Cell; Colorectal Neoplasms; Cystadenocarcinoma, Serous; Diffuse Intrinsic Pontine Glioma; Glioma; Lymphoma; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasm Metastasis; Neuroblastoma; Neurofibromatosis 1; Osteosarcoma; Ovarian Neoplasms; Prostatic Neoplasms; Rhabdoid Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Urinary Bladder Neoplasms; Biliary Tract Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Endometrial Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; Hemangiosarcoma; Lung Neoplasms; Lymphoma, Mantle-Cell; Melanoma; Meningioma; Mesothelioma; Neuroendocrine Tumors; Oligodendroglioma; Paraganglioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung; Liposarcoma; Breast Neoplasms; Neoplasms

Cyclin-dependent kinase 4 inhibitor


Small molecule Approved Unknown Unknown Kidney Diseases; Liver Diseases; Multiple System Atrophy; Parkinson Disease Monoamine oxidase B inhibitor


Small molecule Approved Unknown Unknown Liver Diseases; Pneumonia; Gonorrhea; Infections; Pneumonia, Bacterial; Bacterial Infections Unknown


Small molecule Approved Unknown ORAL Vaginal Discharge; Amebiasis; Trichomonas Infections; Vaginosis, Bacterial DNA inhibitor


Small molecule Approved Unknown Unknown Astrocytoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Kidney Diseases; Lymphoma; Neuroblastoma; Paraganglioma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rhabdoid Tumor; Carcinoma; Carcinoma, Hepatocellular; Fallopian Tube Neoplasms; Liposarcoma; Melanoma; Neoplasms; Neuroendocrine Tumors; Ovarian Neoplasms; Sarcoma; Teratoma; Thymus Neoplasms; Uterine Neoplasms; Breast Neoplasms Cyclin-dependent kinase 4 inhibitor

Small molecule

Approved

Unknown

Astrocytoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Kidney Diseases; Lymphoma; Neuroblastoma; Paraganglioma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rhabdoid Tumor; Carcinoma; Carcinoma, Hepatocellular; Fallopian Tube Neoplasms; Liposarcoma; Melanoma; Neoplasms; Neuroendocrine Tumors; Ovarian Neoplasms; Sarcoma; Teratoma; Thymus Neoplasms; Uterine Neoplasms; Breast Neoplasms

Cyclin-dependent kinase 4 inhibitor


Protein Approved Unknown Unknown Hepatorenal Syndrome; Orthostatic Intolerance; Pre-Eclampsia; Hypertension; Shock, Septic; Cardiovascular Diseases Unknown


Small molecule Approved Unknown Unknown Tourette Syndrome; Trichotillomania; Huntington Disease; Movement Disorders; Schizophrenia Synaptic vesicular amine transporter inhibitor


Antibody Approved Unknown INJECTION Breast Neoplasms; Chronic Urticaria; Dermatitis, Atopic; Hematologic Diseases; Prurigo; Sinusitis; Churg-Strauss Syndrome; Eosinophilic Esophagitis; Hypereosinophilic Syndrome; Nasal Polyps; Pemphigoid, Bullous; Pulmonary Disease, Chronic Obstructive; Asthma; Lung Diseases, Obstructive Interleukin-5 receptor subunit alpha inhibitor


Small molecule Approved Unknown Unknown Kidney Diseases; Liver Diseases; Renal Insufficiency, Chronic; Stress Disorders, Post-Traumatic; Hepatitis C; Hepatitis C, Chronic Hepatitis C virus serine protease, NS3/NS4A inhibitor


Small molecule Approved Unknown Unknown Pancreatitis; Constipation Mu opioid receptor antagonist


Small molecule Approved Unknown ORAL Kidney Diseases; Liver Diseases; Atrial Fibrillation; Atrial Flutter; Hemorrhage; Thromboembolism; Thrombosis; Venous Thromboembolism Coagulation factor X inhibitor


Combination Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown TOPICAL Wounds and Injuries; Impetigo DNA gyrase inhibitor


Unknown Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown ORAL Kidney Diseases; Liver Diseases; Aspergillosis, Allergic Bronchopulmonary; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophies; Muscular Dystrophy, Duchenne Glucocorticoid receptor agonist